Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Aquapharm Bio-Discovery Ltd completes £1.25M funding and is first to locate in the new European Centre for Marine Biotechnology

11.08.2005


Aquapharm Bio – Discovery Ltd (Aquapharm), a leading UK marine biotechnology company developing, amongst other things, anti-infective drug candidates from marine natural products, is pleased to announce the completion this month of its latest round of financing.

The investment of £344000 by E-Synergy Ltd and the Scottish Enterprise Co-Investment Fund completed the £1.25 million package by adding to a recent earlier investment of £350000 (£175,000 each) by NESTA (the National Endowment for Science, Technology and the Arts) and Argyll & the Islands Enterprise (AIE), and thereby paving the way for a future equity investment of £253,400 and grants of up to £300000 from AIE.

Aquapharm was formed in 2000 by Dr Andrew Mearns Spragg & Dr Kathryn Fraser, and is one of the first UK marine biotechnology companies. This funding round has allowed it to expand into new bespoke laboratory facilities within the European Centre for Marine Biotechnology (ECMB), which is situated beside the sea near Oban in Argyll. The Company currently employs a team of 9 full-time staff and has recently strengthened the management team with the addition of three new non-executive directors.



Dr Jo Oliver who through a previous association with SAMS has a knowledge of who is doing what in marine biotechnology, and Mr Colin Garvie, who has extensive financial and commercial experience gained over 25 years which included working with one of the UK’s largest Venture Capital firms, will join long standing non-ex chairman Dr Ron James who provides commercial and deal making support to the board. The incoming investor director, Dr John White, a successful entrepreneur in his own right and a member of E-Synergy’s angel syndicate, will fly his own light aircraft to the local airport to attend board meetings and brings in a wealth of commercial skills.

Dr Andrew Mearns Spragg, the CEO of Aquapharm said “Completing this investment will allow the Company to increase its research programmes including expansion of the project screening of novel marine organisms for new antibiotics. Already, a new anti-infective molecule has been identified that targets multi-drug resistant infections such as MRSA. There is a definite need for new types of antibiotics to combat bacterial infections that have become resistant to most of our available antibiotics” Aquapharm’s other research programmes are the development marine sources of functional foods & organic carotenoid pigments.

The Company also offers access to its growing collection of marine organisms, some of which are new to science, and most of which were collected from Scottish waters, some of the most prolific and cleanest of marine environments in the world, to pharmaceutical and biotech companies that have assays to screen for other drugs, industrial enzymes etc.

Lachie Beaton, a spokesman for AIE said “We are delighted that Aquapharm has completed its funding package.” The ECMB was established along side SAMS to foster commercial development of marine science and build on the world-class academic marine biology we have here. It fits with the objectives of the Smart Successful Scotland programme”. John White added, “We are happy to have made this investment. The work the Company is doing is exciting and we believe, in time, we will make a good return. It is the first investment we have done with the Scottish Co-Investment fund, but I hope it will not be the last.

Joseph Meaney | alfa
Further information:
http://www.aquapharm.co.uk

More articles from Ecology, The Environment and Conservation:

nachricht When corals eat plastics
24.05.2018 | Justus-Liebig-Universität Gießen

nachricht Dispersal of Fish Eggs by Water Birds – Just a Myth?
19.02.2018 | Universität Basel

All articles from Ecology, The Environment and Conservation >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>